Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Family history of type 2 diabetes in schizophrenic patients.

Literature DB >> 2563862

Family history of type 2 diabetes in schizophrenic patients.

S Mukherjee, D B Schnur, R Reddy.

Abstract

Entities: Disease Species

Mesh：

Year: 1989 PMID： 2563862 DOI： 10.1016/s0140-6736(89)91392-5

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

Keyword Cloud
Cited

× No keyword cloud information.

55 in total

Review 1. Schizotaxia: current status and future directions.

Authors: Ming T Tsuang; William S Stone; Franziska Gamma; Stephen V Faraone
Journal: Curr Psychiatry Rep Date: 2003-06 Impact factor: 5.285

Review 2. The interface of psychiatric disorders and diabetes mellitus.

Authors: M K Popkin; E A Colon
Journal: Curr Psychiatry Rep Date: 2001-06 Impact factor: 5.285

Review 3. The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications.

Authors: Roger S McIntyre; Ka Young Park; Candy W Y Law; Farah Sultan; Amanda Adams; Maria Teresa Lourenco; Aaron K S Lo; Joanna K Soczynska; Hanna Woldeyohannes; Mohammad Alsuwaidan; Jinju Yoon; Sidney H Kennedy
Journal: CNS Drugs Date: 2010-09 Impact factor: 5.749

4. Insulin reveals Akt signaling as a novel regulator of norepinephrine transporter trafficking and norepinephrine homeostasis.

Authors: Sabrina D Robertson; Heinrich J G Matthies; W Anthony Owens; Vidiya Sathananthan; Nicole S Bibus Christianson; J Phillip Kennedy; Craig W Lindsley; Lynette C Daws; Aurelio Galli
Journal: J Neurosci Date: 2010-08-25 Impact factor: 6.167

Family history of type 2 diabetes in schizophrenic patients.

Review 1. Schizotaxia: current status and future directions.

Review 2. The interface of psychiatric disorders and diabetes mellitus.

Review 3. The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications.

4. Insulin reveals Akt signaling as a novel regulator of norepinephrine transporter trafficking and norepinephrine homeostasis.

Review 5. Management of antipsychotic-related weight gain.

Review 6. Antipsychotic drugs and diabetes--an application of the Austin Bradford Hill criteria.

7. Parental history of type 2 diabetes in patients with nonaffective psychosis.

Review 8. Toward a model of memory enhancement in schizophrenia: glucose administration and hippocampal function.

9. Differences in glucose tolerance between deficit and nondeficit schizophrenia.

10. Schizophrenia as a systemic disease.